Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05894343 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05894343 · ClinicalTrials.gov record · last posted 2025-08-17

Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease

Name: Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease — clinical trial record (NCT05894343)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 1/2

SponsorMeiraGTx, LLC

Started2023-05-19

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The objective of this study is to evaluate the long-term safety of AAV-GAD delivered bilaterally to the subthalamic nuclei (STN) in participants with Parkinson's disease.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2023-06-07; most recent amendment 2025-08-13. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-08-13

Status change Enrolling by Invitation→Active, Not Recruitingv3

Trial Details

NCT Number	NCT05894343
Lead Sponsor	MeiraGTx, LLC
Conditions	Parkinson's Disease
Enrollment	13 participants
Start Date	2023-05-19
Primary Completion	2029-10 (estimated)
Study Completion	2029-10 (estimated)
Updated on ClinicalTrials.gov	2025-08-17